157 related articles for article (PubMed ID: 24755647)
41. Improved organotypic skin model with reduced quantity of monounsaturated ceramides by inhibiting stearoyl-CoA desaturase-1.
Helder RWJ; Rousel J; Boiten WA; Gooris GS; Nadaban A; El Ghalbzouri A; Bouwstra JA
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Apr; 1866(4):158885. PubMed ID: 33444760
[TBL] [Abstract][Full Text] [Related]
42. Gene expression profiling in skeletal muscle of Zucker diabetic fatty rats: implications for a role of stearoyl-CoA desaturase 1 in insulin resistance.
Voss MD; Beha A; Tennagels N; Tschank G; Herling AW; Quint M; Gerl M; Metz-Weidmann C; Haun G; Korn M
Diabetologia; 2005 Dec; 48(12):2622-30. PubMed ID: 16284748
[TBL] [Abstract][Full Text] [Related]
43. Analysis of sebum lipid composition and the development of acneiform rash before and after administration of egfr inhibitor.
Nakahara T; Moroi Y; Takayama K; Nakanishi Y; Furue M
Curr Oncol; 2015 Apr; 22(2):e124-7. PubMed ID: 25908917
[TBL] [Abstract][Full Text] [Related]
44. Stearoyl-CoA desaturase-1 (SCD1) augments saturated fatty acid-induced lipid accumulation and inhibits apoptosis in cardiac myocytes.
Matsui H; Yokoyama T; Sekiguchi K; Iijima D; Sunaga H; Maniwa M; Ueno M; Iso T; Arai M; Kurabayashi M
PLoS One; 2012; 7(3):e33283. PubMed ID: 22413010
[TBL] [Abstract][Full Text] [Related]
45. Expression and regulation of delta5-desaturase, delta6-desaturase, stearoyl-coenzyme A (CoA) desaturase 1, and stearoyl-CoA desaturase 2 in rat testis.
Saether T; Tran TN; Rootwelt H; Christophersen BO; Haugen TB
Biol Reprod; 2003 Jul; 69(1):117-24. PubMed ID: 12606372
[TBL] [Abstract][Full Text] [Related]
46. Benzimidazole-carboxamides as potent and bioavailable stearoyl-CoA desaturase (SCD1) inhibitors from ligand-based virtual screening and chemical optimization.
Matter H; Zoller G; Herling AW; Sanchez-Arias JA; Philippo C; Namane C; Kohlmann M; Pfenninger A; Voss MD
Bioorg Med Chem Lett; 2013 Mar; 23(6):1817-22. PubMed ID: 23395660
[TBL] [Abstract][Full Text] [Related]
47. Knockout of Stearoyl-CoA Desaturase 1 Decreased Milk Fat and Unsaturated Fatty Acid Contents of the Goat Model Generated by CRISPR/Cas9.
Tian H; Niu H; Luo J; Yao W; Chen X; Wu J; Geng Y; Gao W; Lei A; Gao Z; Tian X; Zhao X; Shi H; Li C; Hua J
J Agric Food Chem; 2022 Apr; 70(13):4030-4043. PubMed ID: 35343224
[TBL] [Abstract][Full Text] [Related]
48. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
49. Thiazole analog as stearoyl-CoA desaturase 1 inhibitor.
Li CS; Belair L; Guay J; Murgasva R; Sturkenboom W; Ramtohul YK; Zhang L; Huang Z
Bioorg Med Chem Lett; 2009 Sep; 19(17):5214-7. PubMed ID: 19632834
[TBL] [Abstract][Full Text] [Related]
50. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.
Fritz V; Benfodda Z; Rodier G; Henriquet C; Iborra F; Avancès C; Allory Y; de la Taille A; Culine S; Blancou H; Cristol JP; Michel F; Sardet C; Fajas L
Mol Cancer Ther; 2010 Jun; 9(6):1740-54. PubMed ID: 20530718
[TBL] [Abstract][Full Text] [Related]
51. Discovery of piperazin-1-ylpyridazine-based potent and selective stearoyl-CoA desaturase-1 inhibitors for the treatment of obesity and metabolic syndrome.
Zhang Z; Sun S; Kodumuru V; Hou D; Liu S; Chakka N; Sviridov S; Chowdhury S; McLaren DG; Ratkay LG; Khakh K; Cheng X; Gschwend HW; Kamboj R; Fu J; Winther MD
J Med Chem; 2013 Jan; 56(2):568-83. PubMed ID: 23245208
[TBL] [Abstract][Full Text] [Related]
52. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance.
Gutiérrez-Juárez R; Pocai A; Mulas C; Ono H; Bhanot S; Monia BP; Rossetti L
J Clin Invest; 2006 Jun; 116(6):1686-95. PubMed ID: 16741579
[TBL] [Abstract][Full Text] [Related]
53. Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery.
Brown JM; Rudel LL
Curr Opin Lipidol; 2010 Jun; 21(3):192-7. PubMed ID: 20216310
[TBL] [Abstract][Full Text] [Related]
54. Hepatic knockdown of stearoyl-CoA desaturase 1 via RNA interference in obese mice decreases lipid content and changes fatty acid composition.
Xu H; Wilcox D; Nguyen P; Voorbach M; Smith H; Brodjian S; Suhar T; Reilly RM; Jacobson PB; Collins CA; Landschulz K; Surowy TK
Front Biosci; 2007 May; 12():3781-94. PubMed ID: 17485339
[TBL] [Abstract][Full Text] [Related]
55. Epigenetic mechanisms contribute to decrease stearoyl-CoA desaturase 1 expression in the liver of dairy cows after prolonged feeding of high-concentrate diet.
Xu TL; Seyfert HM; Shen XZ
J Dairy Sci; 2018 Mar; 101(3):2506-2518. PubMed ID: 29274956
[TBL] [Abstract][Full Text] [Related]
56. Azacycloalkane derivatives as inhibitors of delta-9 stearoyl-coenzyme A desaturase.
Liu G
Expert Opin Ther Pat; 2009 Jun; 19(6):885-91. PubMed ID: 19473107
[TBL] [Abstract][Full Text] [Related]
57. Obesity resistance of the stearoyl-CoA desaturase-deficient (scd1-/-) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation.
Binczek E; Jenke B; Holz B; Günter RH; Thevis M; Stoffel W
Biol Chem; 2007 Apr; 388(4):405-18. PubMed ID: 17391062
[TBL] [Abstract][Full Text] [Related]
58. Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans.
Peter A; Cegan A; Wagner S; Elcnerova M; Königsrainer A; Königsrainer I; Häring HU; Schleicher ED; Stefan N
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E321-6. PubMed ID: 21045174
[TBL] [Abstract][Full Text] [Related]
59. Dihydrosterculic acid from cottonseed oil suppresses desaturase activity and improves liver metabolomic profiles of high-fat-fed mice.
Paton CM; Vaughan RA; Selen Alpergin ES; Assadi-Porter F; Dowd MK
Nutr Res; 2017 Sep; 45():52-62. PubMed ID: 29037332
[TBL] [Abstract][Full Text] [Related]
60. Adipose-specific deletion of stearoyl-CoA desaturase 1 up-regulates the glucose transporter GLUT1 in adipose tissue.
Hyun CK; Kim ED; Flowers MT; Liu X; Kim E; Strable M; Ntambi JM
Biochem Biophys Res Commun; 2010 Sep; 399(4):480-6. PubMed ID: 20655875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
